Peptide COAs

Nad+

32 public audits matching your filters. Scores are PeptIQ’s legitimacy model; missing panels lower thoroughness but aren’t automatically “bad” — open a report to see pass, fail, reported, and missing panels clearly.

Public certificates

Approved community and directory-linked COAs only.

  • NAD+ + NAD+ 1000mg

    American Peptides · Sep 5, 2026 · Core panels 100% · 5/7 panels · 99.9% purity · Doc 92

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns80Solid
  • NAD+

    Crush Research · Sep 5, 2026 · Core panels 100% · 5/7 panels · 99% purity · Doc 95

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns79Solid
  • NAD 500mg + NAD+

    Crush Research · Sep 5, 2026 · Core panels 100% · 5/7 panels · 99% purity · Doc 92

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns79Solid
  • NAD+

    Crush Research · Sep 5, 2026 · Core panels 100% · 5/7 panels · 99.38% purity · Doc 95

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns79Solid
  • NAD+ + Nicotinamide adenine dinucleotide

    American Peptide Research · Sep 5, 2026 · Core panels 100% · 2/7 panels · 99.45% purity · Doc 92

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns77Solid
  • NAD+ + Nicotinamide Adenine Dinucleotide

    American Peptide Research · Sep 5, 2026 · Core panels 100% · 2/7 panels · Doc 72

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns77Solid
  • NAD+ + Nicotinamide Adenine Dinucleotide

    American Peptide Research · Sep 5, 2026 · Core panels 100% · 2/7 panels · 99.52% purity · Doc 92

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns77Solid
  • NAD+ + Nicotinamide Adenine Dinucleotide

    American Peptide Research · Sep 5, 2026 · Core panels 100% · 2/7 panels · 99.52% purity · Doc 92

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns77Solid
  • NAD+ + Nicotinamide Adenine Dinucleotide

    American Peptide Research · Sep 5, 2026 · Core panels 100% · 2/7 panels · 99.45% purity · Doc 92

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns77Solid
  • NAD+ + NAD+ 500mg BUFFERED

    Blank Peptides · Sep 5, 2026 · Core panels 100% · 4/7 panels · 99.91% purity · Doc 88

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns76Solid
  • NAD+ + NAD+ 500mg (Buffered)

    Blank Peptides · Sep 5, 2026 · Core panels 100% · 3/7 panels · 99.52% purity · Doc 88

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns76Solid
  • NAD+ + NAD+ 1000mg

    Blank Peptides · Sep 5, 2026 · Core panels 100% · 4/7 panels · 99.24% purity · Doc 72

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns76Solid
  • NAD+ + NAD+ 1000mg

    Blank Peptides · Sep 5, 2026 · Core panels 100% · 4/7 panels · 99.97% purity · Doc 72

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns76Solid
  • NAD+ + Nicotinamide Adenine Dinucleotide

    Blank Peptides · Sep 5, 2026 · Core panels 67% · 2/7 panels · 99.94% purity · Doc 72

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns76Solid
  • NAD+

    Blank Peptides · Sep 5, 2026 · Core panels 100% · 3/7 panels · 99.35% purity · Doc 88

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns76Solid
  • NAD+ + Nicotinamide Adenine Dinucleotide

    Blank Peptides · Sep 5, 2026 · Core panels 67% · 2/7 panels · 99.94% purity · Doc 72

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns76Solid
  • NAD+ + Nicotinamide Adenine Dinucleotide

    Blank Peptides · Sep 5, 2026 · Core panels 67% · 2/7 panels · 99.85% purity · Doc 72

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns76Solid
  • NAD+

    Blank Peptides · Sep 5, 2026 · Core panels 100% · 2/7 panels · 99.895% purity · Doc 15

    Multiple signals on this document conflict with known lab formats or verification patterns.

    Evidence suggests fabrication76Solid
  • NAD+

    Peptide Partners · Sep 5, 2026 · Core panels 33% · 1/7 panels · Doc 72

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns73Solid
  • NAD+

    Peptide Partners · Sep 5, 2026 · Core panels 33% · 1/7 panels · Doc 88

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns73Solid
  • NAD+ + Nicotinamide Adenine Dinucleotide

    Peptide Partners · Sep 5, 2026 · Core panels 67% · 2/7 panels · 99.56% purity · Doc 92

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns73Solid
  • NAD+ + Unbuffered NAD+ 750mg

    Peptide Partners · Sep 5, 2026 · Core panels 33% · 1/7 panels · Doc 72

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns73Solid
  • Buffered NAD+

    Peptide Partners · Sep 5, 2026 · Core panels 100% · 1/7 panels · Doc 72

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns73Solid
  • NAD+

    Peptide Partners · Sep 5, 2026 · Core panels 33% · 1/7 panels · Doc 72

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns73Solid
  • NAD+ + Nicotinamide adenine dinucleotide

    Peptide Partners · Sep 5, 2026 · Core panels 67% · 2/7 panels · 99.76% purity · Doc 72

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns73Solid
  • NAD+ + NAD+ 500mg

    Brand not listed · Jul 28, 2026 · Core panels 67% · 2/7 panels · 99.86% purity

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns72Doc score
  • NAD+

    Retalux · Sep 5, 2026 · Core panels 100% · 3/7 panels · 99.505% purity · Doc 72

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns71Solid
  • NAD+

    Retalux · Sep 5, 2026 · Core panels 67% · 2/7 panels · 96.46% purity · Doc 92

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns71Solid
  • NAD+

    Pepturion · Sep 5, 2026 · Core panels 100% · 3/7 panels · 99.07% purity · Doc 92

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns63Mixed signals
  • NAD+

    Lumira · Sep 5, 2026 · Core panels 100% · 4/7 panels · Doc 15

    Multiple signals on this document conflict with known lab formats or verification patterns.

    Evidence suggests fabrication58Mixed signals
  • NAD+ + NAD+ 500mg

    Lumira · Sep 5, 2026 · Core panels 67% · 2/7 panels · Doc 45

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns58Mixed signals
  • NAD (+) + NAD+

    Lumira · Sep 5, 2026 · Core panels 67% · 2/7 panels · 99.7% purity · Doc 92

    Several fields check out, but we found issues worth reviewing before you rely on this document.

    Mostly consistent, with concerns58Mixed signals

Community-sourced

Help build the COA record

PeptIQ’s market snapshot comes from moderator-approved certificates and curated peptide brands and testing laboratories — not invented stats. Contribute a COA or claim your listing.

Community submissions are reviewed before they appear on public market pages. Private COA scans stay private until you share them.

Brand owners: claim or list your peptide brand, upload COAs tied to it in the app, then track trust scores on your public brand page and the COA market.

PeptIQ COA reports analyze document content and publicly verifiable lab signals. They are educational and not a guarantee of product quality, legality, or safety. Always consult a qualified professional before making health decisions. We never publish purchase prices, shipping details, or uploader identity.